Use of outpatient rheumatologic health care services before and after switch from originator to biosimilar infliximab

B Glintborg, J Sørensen, ML Hetland

34 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	THU0648
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	76
Udgave nummer	Suppl 2
Sider (fra-til)	450-451
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2017-eular.3008
Status	Udgivet - 2017

Adgang til dokumentet

@article{f7391e25afb74573932bbdad8f71772d,

title = "Use of outpatient rheumatologic health care services before and after switch from originator to biosimilar infliximab",

author = "B Glintborg and J S{\o}rensen and ML Hetland",

year = "2017",

doi = "10.1136/annrheumdis-2017-eular.3008",

language = "English",

volume = "76",

pages = "450--451",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - Use of outpatient rheumatologic health care services before and after switch from originator to biosimilar infliximab

AU - Glintborg, B

AU - Sørensen, J

AU - Hetland, ML

PY - 2017

Y1 - 2017

U2 - 10.1136/annrheumdis-2017-eular.3008

DO - 10.1136/annrheumdis-2017-eular.3008

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 450

EP - 451

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - THU0648

ER -